Medication info
Abatril Tablet 5/160/10 mg

Abatril Tablet 5/160/10 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletValsartan›160mg / 1 tabletAtorvastatin Calcium Hydrate›10.85mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Light brownish-yellow oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202006662 · Approved 2020.09.25 · Insurance code 669908040

Summary

Main use
Treatment of essential hypertension, improvement of dyslipidemia, prevention of cardiovascular disease
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for use in adults only. The dosage should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. For patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended to adjust the dose using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. The amlodipine/valsartan combination should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or greater). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. - Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. - Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, improvement of dyslipidemia, prevention of cardiovascular disease

  • Essential hypertension
  • myocardial infarction
  • stroke
  • vascular surgery
  • chronic stable angina
  • retinopathy
  • albuminuria
  • dyslipidemia
  • hypercholesterolemia
  • mixed dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication is used for patients whose hypertension is not adequately controlled with amlodipine and valsartan combination therapy, and it is suitable for those who need to be treated with atorvastatin at the same time. The amlodipine/valsartan combination helps effectively control essential hypertension. Atorvastatin plays a crucial role in lowering the risk of cardiovascular diseases, especially reducing the risk of coronary heart disease and stroke. Moreover, it lowers the risk of myocardial infarction, stroke, complications after vascular surgery, angina, and hospitalization for congestive heart failure in patients with diabetes or symptoms of cardiovascular disease. This medication also improves cholesterol and triglyceride levels in patients with dyslipidemia, contributing to the maintenance of vascular health. Therefore, this medication effectively improves cardiovascular health by managing hypertension and dyslipidemia.

How to take

Adult dose

Take 1 tablet once daily with water. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for use in adults only. The dosage should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. For patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended to adjust the dose using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. The amlodipine/valsartan combination should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or greater). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. - Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. - Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. If muscle-related abnormal symptoms appear or muscle enzyme levels rise significantly in blood tests, the use of this medication should be discontinued, especially in patients at high risk of severe myopathy. Patients who have an allergy to any ingredient of this medication or who have certain liver or kidney diseases, as well as pregnant or breastfeeding women, should not take this medication. Patients with insufficient sodium or body fluids, hyperkalemia, renal artery stenosis, kidney transplant patients, and those with a history of angioedema should be extremely cautious when using this medication and require close monitoring by a physician. Patients with heart diseases such as heart failure or post-myocardial infarction patients, as well as patients with aortic valve stenosis, should also be careful when using this medication. This medication may interact with various drugs, so if taking other medications, it is essential to inform the doctor or pharmacist, especially when used in combination with certain antibiotics, antifungals, HIV treatments, some diuretics, and potassium supplements. Dizziness or fatigue may occur during use, so caution is required when driving or operating machinery. If symptoms such as liver dysfunction, muscle pain, muscle weakness, rash, or difficulty breathing occur, immediate consultation with a healthcare provider is necessary. Women of childbearing age should use appropriate contraceptive methods while taking this medication, and breastfeeding women are advised not to take this medication.

Side effects

  • Dry eyes
  • nausea
  • headache
  • nasopharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • dizziness
  • drowsiness
Show 139 more
  • positional dizziness
  • paresthesia
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • pharyngeal and laryngeal pain
  • diarrhea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • sweating
  • itching
  • joint swelling
  • low back pain
  • arthritis
  • muscle cramping
  • weakness
  • polyuria
  • polydipsia
  • erectile dysfunction
  • edema
  • localized edema
  • facial edema
  • peripheral edema
  • fatigue
  • flushing
  • asthenia
  • facial flushing
  • double vision
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • dysgeusia
  • peripheral neuropathy
  • muscle tension
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • angioedema
  • vesicular dermatitis
  • myalgia
  • renal failure
  • kidney damage
  • elevated serum creatinine
  • lethargy
  • malaise
  • chest pain
  • fatigue
  • fever
  • hyperglycemic episode
  • hypoglycemia
  • weight gain
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • nosebleed
  • nightmares
  • perceptual disturbances
  • memory loss
  • peripheral neuropathy
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • tinnitus
  • hearing loss
  • urticaria
  • angioneurotic edema
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urinary leukocytes
  • muscle cramps
  • muscle fatigue
  • myositis
  • muscle disease
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • neck pain
  • tendon contracture
  • thrombocytopenia
  • anaphylaxis
  • jaundice
  • fulminant hepatitis
  • hepatitis
  • vasculitis
  • serum sickness
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory infection
  • viral infection
  • intestinal vascular edema
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux disease
  • throat pain
  • hypercholesterolemia
  • hypoglycemia
  • nocturia
  • Stevens-Johnson syndrome
  • rhabdomyolysis
  • thrombocytopenia
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help to maintain the efficacy and safety of the medication for a longer time.

Appearance and packaging

Appearance

Light brownish-yellow oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.